News and Events

On the Driven to Discover podcast, Henry Louis Taylor explains how transforming neighborhoods will improve health outcomes
12/18/24
In this episode of UB’s research podcast Driven to Discover, Henry-Louis Taylor, Jr., talks about what led him to launch his latest and most ambitious project: The East Side Neighborhood Transformation Project.
Two UB studies on MS patients reveal how paramagnetic rim lesions evolve and what they mean for disease progression
12/11/24
UB researchers have published the first longitudinal studies of paramagnetic rim lesions, an indicator of brain inflammation in MS.
UB expert part of FDA committee that looked at AI-enabled medical devices
12/9/24
Peter Elkin was invited to serve on the FDA's Digital Health Advisory Committee.
NEJM study: For chronic subdural hematomas, blocking the artery supplying the brain covering reduced re-operations threefold
11/20/24
A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how
11/13/24
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.

Events Calendar